The influence of pulmonary surfactant on nanoparticulate drug delivery systems

Schleh, Carsten; Rothen-Rutishauser, Barbara; Kreyling, Wolfgang G (2011). The influence of pulmonary surfactant on nanoparticulate drug delivery systems. European journal of pharmaceutics and biopharmaceutics, 77(3), pp. 350-2. Amsterdam: Elsevier 10.1016/j.ejpb.2010.12.025

Full text not available from this repository. (Request a copy)

The pulmonary route is very attractive for drug delivery by inhalation. In this regard, nanoparticulate drug delivery systems, designed as multifunctional engineered nanoparticles, are very promising since they combine several opportunities like a rather uniform distribution of drug dose among all ventilated alveoli allowing for uniform cellular drug internalization. However, although the field of nanomedicine offers multiple opportunities, it still is in its infancy and the research has to proceed in order to obtain a specific targeting of the drug combined with minimum side effects. If inhaled nanoparticulate drug delivery systems are deposited on the pulmonary surfactant, they come into contact with phospholipids and surfactant proteins. It is highly likely that the interaction of nanoparticulate drug delivery systems with surfactant phospholipids and proteins will be able to mediate/modulate the further fate of this specific drug delivery system. In the present comment, we discuss the potential interactions of nanoparticulate drug delivery systems with pulmonary surfactant as well as the potential consequences of this interaction.

Item Type:

Journal Article (Original Article)


04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Pneumology

UniBE Contributor:

Rothen-Rutishauser, Barbara








Factscience Import

Date Deposited:

04 Oct 2013 14:09

Last Modified:

04 May 2014 23:04

Publisher DOI:


PubMed ID:


Web of Science ID:


URI: (FactScience: 201732)

Actions (login required)

Edit item Edit item
Provide Feedback